101 related articles for article (PubMed ID: 19688827)
1. Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.
Shafer A; Zhou C; Gehrig PA; Boggess JF; Bae-Jump VL
Int J Cancer; 2010 Mar; 126(5):1144-54. PubMed ID: 19688827
[TBL] [Abstract][Full Text] [Related]
2. Comparing mTOR inhibitor Rapamycin with Torin-2 within the RIST molecular-targeted regimen in neuroblastoma cells.
Waetzig R; Matthes M; Leister J; Penkivech G; Heise T; Corbacioglu S; Sommer G
Int J Med Sci; 2021; 18(1):137-149. PubMed ID: 33390782
[TBL] [Abstract][Full Text] [Related]
3. Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer
O'Donnell J; Zhao Z; Buckingham L; Hao T; Suo H; Zhang X; Fan Y; John C; Deng B; Shen X; Sun W; Secord AA; Zhou C; Bae-Jump VL
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503790
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel promotes mTOR signaling-mediated apoptosis in esophageal cancer cells by targeting MUC20.
Li M; Feng Z; Han R; Hu B; Zhang R; Wang H
Thorac Cancer; 2023 Nov; 14(31):3089-3096. PubMed ID: 37772424
[TBL] [Abstract][Full Text] [Related]
5. Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in
Corr BR; Moroney MR; Woodruff E; Watson ZL; Jordan KR; Danhorn T; Bailey C; Wolsky RJ; Bitler BG
bioRxiv; 2023 Apr; ():. PubMed ID: 37066339
[TBL] [Abstract][Full Text] [Related]
6. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
[TBL] [Abstract][Full Text] [Related]
7. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pH-Sensitive Polymeric Micelles Using Citraconic Amide Bonds for the Co-Delivery of Paclitaxel, Etoposide, and Rapamycin.
Jo MJ; Shin HJ; Yoon MS; Kim SY; Jin CE; Park CW; Kim JS; Shin DH
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678783
[TBL] [Abstract][Full Text] [Related]
9. Effect of rapamycin treatment in human seminoma TCam-2 cells through inhibition of G1-S transition.
Onel T; Erdogan CS; Aru B; Yildirim E; Demirel GY; Yaba A
Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):1009-1018. PubMed ID: 36598515
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.
Ibrahim SL; Abed MN; Mohamed G; Price JC; Abdullah MI; Richardson A
Br J Cancer; 2023 Mar; 128(5):896-906. PubMed ID: 36526674
[TBL] [Abstract][Full Text] [Related]
11. The autophagy inducer SMER28 attenuates microtubule dynamics mediating neuroprotection.
Kirchenwitz M; Stahnke S; Grunau K; Melcher L; van Ham M; Rottner K; Steffen A; Stradal TEB
Sci Rep; 2022 Oct; 12(1):17805. PubMed ID: 36284196
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.
Sharifi-Rad J; Quispe C; Patra JK; Singh YD; Panda MK; Das G; Adetunji CO; Michael OS; Sytar O; Polito L; Živković J; Cruz-Martins N; Klimek-Szczykutowicz M; Ekiert H; Choudhary MI; Ayatollahi SA; Tynybekov B; Kobarfard F; Muntean AC; Grozea I; Daştan SD; Butnariu M; Szopa A; Calina D
Oxid Med Cell Longev; 2021; 2021():3687700. PubMed ID: 34707776
[TBL] [Abstract][Full Text] [Related]
13. Optimization and Pharmacokinetic Evaluation of Synergistic Fenbendazole and Rapamycin Co-Encapsulated in Methoxy Poly(Ethylene Glycol)-
Shin HJ; Jo MJ; Jin IS; Park CW; Kim JS; Shin DH
Int J Nanomedicine; 2021; 16():4873-4889. PubMed ID: 34295160
[TBL] [Abstract][Full Text] [Related]
14. Novel Benzenesulfonate Scaffolds with a High Anticancer Activity and G2/M Cell Cycle Arrest.
Malarz K; Mularski J; Kuczak M; Mrozek-Wilczkiewicz A; Musiol R
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918637
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
[TBL] [Abstract][Full Text] [Related]
16. High-throughput, microscope-based sorting to dissect cellular heterogeneity.
Hasle N; Cooke A; Srivatsan S; Huang H; Stephany JJ; Krieger Z; Jackson D; Tang W; Pendyala S; Monnat RJ; Trapnell C; Hatch EM; Fowler DM
Mol Syst Biol; 2020 Jun; 16(6):e9442. PubMed ID: 32500953
[TBL] [Abstract][Full Text] [Related]
17. The role of RICTOR amplification in targeted therapy and drug resistance.
Zhao D; Jiang M; Zhang X; Hou H
Mol Med; 2020 Feb; 26(1):20. PubMed ID: 32041519
[TBL] [Abstract][Full Text] [Related]
18. Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo.
Cao C; Zhou JY; Xie SW; Guo XJ; Li GT; Gong YJ; Yang WJ; Li Z; Zhong RH; Shao HH; Zhu Y
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284427
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines.
Effendi WI; Nagano T; Tachihara M; Umezawa K; Kiriu T; Dokuni R; Katsurada M; Yamamoto M; Kobayashi K; Nishimura Y
Cancer Manag Res; 2019; 11():3669-3679. PubMed ID: 31118789
[No Abstract] [Full Text] [Related]
20. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro.
Ayuk SM; Abrahamse H
Cells; 2019 May; 8(5):. PubMed ID: 31075885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
